Precision Therapeutics Against Solid Cancers

Board of Directors

Prof. Rolf Krebs, M.D. (Chair)

Prof. Dr. Dr. h.c. Rolf Krebs is the former Chairman of the Board of Managing Directors of Boehringer Ingelheim GmbH and holds various posts in the Supervisory and Advisory Boards of major international companies.


Prof. Christoph Huber, M.D. (Vice Chair)

Prof. Dr. Christoph Huber is emeritus professor and the former Head of the department of Hematology and Oncology at the Johannes Gutenberg University Medical School in Mainz, Germany.


Wolfgang Boorberg

Wolfgang Boorberg is a German Certified Public Accountant, Tax Adviser and Consultant in legal affairs. He is shareholder and CEO of Boorberg GmbH Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft in Stuttgart and member of several advisory boards of German companies.


Helmut Jeggle

Helmut Jeggle is responsible for the pharmaceutical and biotechnology initiatives of Athos GmbH, the family office of the Strüngmann brothers.


Axel H. Leimer

Axel H. Leimer is the founder of Leimer Industry Strategy Consulting and is an adviser to Future Capital AG.


Walter Pörschmann

Walter Pörschmann is the former Corporate Senior Vice President at Boehringer Ingelheim as well as the former Chairman of the International Committee of the German Association of Research-Based Pharmaceutical Companies.

News

[Dezember 2012]

Richtfest Biotech-Campus
"An der Goldgrube"

Investitionsvolumen 34 Mio. Euro / Entwicklung spezifischer Krebstherapien

Associations

Biotechnologie-Industrie-Organisation Deutschland e.V.

Ganymed belongs to CI3 - Cluster of

"individualized immunointervention -

ImmunoPolis"

Association for Cancer Immunotherapy